Scott is President, CEO, and co-founder of Vodori. With over 20 years of life science experience, Scott is responsible for company strategy, business development, and helping Vodorians maximize their potential. Scott graduated from the University of Illinois at Urbana-Champaign with a degree in Economics.
Grant is CTO and co-founder of Vodori. Grant is responsible for Vodori’s Product R&D, platform architecture and strategy. Grant graduated from Northwestern University in 2002 with a degree in Computer Information Systems. He has been building enterprise systems for customers in life sciences for more than 17 years.
Stacy is VP, Product Strategy and co-founder of Vodori. She has spent 20+ years partnering with life sciences organizations to implement enterprise business intelligence and content management solutions. She is responsible for continuously advancing Vodori’s overall product vision and strategy, ensuring that we help create transparency and authenticity between life sciences organizations and the patients they serve. Stacy graduated from the University of Wisconsin, Madison with a BS in Civil Engineering.
Board of Directors
Richard Gochnauer, lead director. Richard retired in 2011 as Chief Executive Officer of United Stationers, a leading wholesale distributor of office and business products. From 1994 until he joined United in 2002, Richard held the positions of Vice Chairman and President, International, and President and Chief Operating Officer of Golden State Foods (GSF). Prior to GSF, Richard served as Executive Vice President of the Dial Corporation where he was responsible for their Household Consumer Products businesses. Richard is a current member of the board of AmerisourceBergen Corporation, UGI Corporation, Golden State Foods, and The Center for Higher Ambition Leadership. He earned a Masters degree in Business Administration from Harvard Graduate School of Business and a Bachelor of Science degree in Industrial Engineering from Northwestern University.
Dan Reiner is a founder, investor, and/or a director of more than a dozen companies in the public and private sectors, spanning multiple markets from biotechnology to real estate. He was the Founding CEO and Executive Chairman of Stemcentrx, a cancer drug development firm sold to Abbvie for $5.8+ billion in 2016. Prior to Stemcentrx, Daniel was formerly Chairman and CEO of telecommunications equipment company World Wide Packets. Daniel was an investor, executive and board member for VaxGen, a spin out from Genentech, which executed on a Phase III clinical trial of an AIDS vaccine. He holds an MBA from Pepperdine University and has undertaken graduate studies in genetics and biochemistry at Wayne State University and the University of California, San Diego.
Feyzi Fatehi is Silicon Valley veteran of Hewlett Packard and multiple disruptive technology start-ups that generated over $1 billion in shareholder value. He currently serves as the Chairman and CEO of Corent Tech – a disruptive innovator in the Cloud and SaaS technologies, that was named among the Top 10 Cloud Technology Solution Providers, and The Most Disruptive Private Companies in 2018. Feyzi–who was recognized as Entrepreneur of the Year by the Orange County Business Journal–is an avid supporter of entrepreneurship and education. He studied at Cambridge, Princeton, UT Austin, and UCLA, and serves as an advisor to UCLA Anderson School of Management, UCI Schools of Engineering and Computer Sciences, and the Beall Center for Innovation & Entrepreneurship.
Jim Hussey is currently CEO and member of the Board of Directors of Seneca Therapeutics, a clinical stage biopharmaceutical company dedicated to the development of oncolytic immune therapeutics based on Seneca Valley Virus (SVV-001). Jim has been a CEO or President for nearly 20 years, has been a member of the C-Suite at several successful biotech/pharmaceutical companies and has deep experience in leading and growing technology start-up companies.
In his 35+ year career in pharmaceutical and biotech companies, Hussey has served in roles ranging from CEO of Nanolink, NeoPharm and Physicians Quality Care, to President at Sagent Pharmaceuticals, Executive Vice President at Athenex, and General Manager at Bristol-Myers Squibb.
Richard Gadbois is currently a Senior Advisor to Oakmont Corporation, a $2.5 Billion family office for Robert Day, where he has maintained an investment relationship since 1989. He is also Chairman of HS Group, an Asian-focused alternative asset management seeding firm. In 1994 Richard became a Senior Vice President with Merrill Lynch, where he advised insiders at public companies in the US and Europe. He retired from Merrill in 2001 with client assets of over $3 Billion. He has served as Director of several public companies and charitable organizations over the last 20 years. Richard graduated from the University of California, Santa Barbara with a BA in Economics.
Prior to its acquisition by SAP in 2012, Rich was founder and CEO of Syclo, a provider of mobile applications and mobile enterprise software development platform He headed SAP’s mobile strategy until July 2014, but left the company to return to his startup roots, co-founding Deep Dish Technology, a development lab in Chicago where he and his team explore new technologies and incubate solutions, taking some to market. Rich currently serves on the faculty at Northwestern University, teaching at the Farley Center for Entrepreneurship and mentoring students at The Garage, NU’s innovation hub. He received a BS in Industrial Engineering from Northwestern University.
Dennis Sweeney spent 22 years with McKinsey & Company, an international consulting firm, where he was a senior partner. During his years with McKinsey, he consulted with clients in the High Tech, Entertainment, Energy, Engineering and Construction, Healthcare, and Internet Commerce industries. Mr. Sweeney chairs the board of Pharos Innovations, a Chicago-based health care services company and he serves on the board of Plum Healthcare, a California-based provider of post-acute care services. He is a cofounder and board chair for the Rising Tide Transitional Housing Program in Orange County, which provides housing and transition services for youth emancipating at age 18 from the foster care system. Dennis received his undergraduate degree in economics from Princeton, and then served for four years in the U.S. Army as a Field Artillery officer, earning both Airborne and Ranger qualifications. He received his M.B.A., with distinction, from Harvard Business School.
Kurt founded K8 Ventures, an early stage venture fund that focuses on creating, incubating and accelerating companies from concept to market. He is also a Venture Advisor to Purple Arch Ventures, which focuses on early stage investments in companies founded by Northwestern University alumni. Kurt has Fortune 500 and entrepreneurial leadership experience, and has developed a business framework for growth that has been proven out in the spectrum of pre-revenue startups to multi-billion dollar enterprises. Over his sales and management career has sold over $300 million in goods and services for F500 companies that include Baxter Healthcare, Verizon, EDS, and British Telecom. As a corporate leader, he has held P&L responsibility for Western Europe, Latin America, and Asia Pacific, as well as launched non-US multi-nationals in North America. He now serves as an advisor to the Vodori Leadership team.
Lesly Marban is a visionary, purpose-driven marketing, branding, and strategy expert with experience leading generic and branded pharmaceutical products, medical devices, and supplies. She is currently founder and principal of Diberin Solutions, which provides industry expertise and management consulting to high-growth startups and small to medium sized companies focused on medical devices, pharmaceutical, biotech and contract services. Prior to Diberin Solutions, Lesly was Chief Marketing Officer of Medline Industries, Inc. where she oversaw the medical supplier’s overall brand strategy and found new ways to position the company for growth, including leading new market entry initiatives that drove over $1 billion of incremental sales within four years. Ms. Marban joined Medline after a 17-year career at Baxter. She serves as an advisor to the Vodori Marketing & Leadership teams.
Attorney Brian Parker, Partner at Parker Poe Adams & Bernstein LLP, has over 20 years of experience advising branded and generic pharmaceutical, biopharma, and biotech companies in the areas of medical, legal, and regulatory. These life science and healthcare companies range in revenue from 50M–75B and include some of the largest companies in the S&P 500 Index. He regularly works with life science and healthcare C-Suite executives, Directors, and Management professionals on developing and implementing strategies involving marketing, sales and business development to achieve sustainable recurring revenue growth. He has a proven track record working alongside pharmaceutical and healthcare executives on key performance indicators in developing cross-selling strategies across various verticals to improve cash flow, profitability, and lifetime customer value. He currently serves on multiple for-profit and non-profit boards. He serves as advisor to the Vodori Marketing and Leadership Team.
Will has a successful track record of building best-in-class brands and growing market share for emerging tech companies. He was Senior Vice President and Chief Marketing Officer at SpringCM, which was acquired by DocuSign in 2018; was Chief Marketing Officer at SteelBrick which was acquired by Salesforce in 2016; and was Vice President of Marketing at BigMachines which was acquired by Oracle in 2013. He currently serves as advisor and coach to Vodori Marketing and Leadership teams.